Regeneron and Lilly antibody drug cocktails reportedly lose effectiveness against the omicron variant
This according to a WSJ report, with Regeneron saying that its COVID-19 antibody drug cocktail was found to lose effectiveness against omicron based on preliminary tests. Adding that perhaps there needs to be a modification if the new strain becomes widespread.
This according to a WSJ report, with Regeneron saying that its COVID-19 antibody drug cocktail was found to lose effectiveness against omicron based on preliminary tests. Adding that perhaps there needs to be a modification if the new strain becomes widespread.